GlassScriptPhysician profile
Timothy R Ivey
NPI 1902802333
$11,790.80
in general payments reported to CMS, 2019-2025
47 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $1,134 · 2021: $2,288 · 2022: $1,851 · 2023: $1,999 · 2024: $2,128 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,333.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,830.46 | 2021-2025 | |
| Novo Nordisk INC | $1,057.52 | 2019-2024 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,033.61 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $836.85 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $694.14 | 2019-2025 | Freestyle Libre, Freestyle Libre 2 |
| Xeris Pharmaceuticals, INC. | $671.80 | 2021-2025 | Gvoke Hypopen, Keveyis, Recorlev |
| Insulet Corporation | $460.44 | 2022-2024 | Omnipod |
| Renalytix Ai, INC. | $401.07 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Bayer Healthcare Pharmaceuticals INC. | $372.63 | 2023-2025 | |
| Glaxosmithkline, LLC. | $371.42 | 2019-2025 | Trelegy Ellipta, Arexvy, Boostrix |
| Sanofi-Aventis U.S. LLC | $348.58 | 2019-2024 | |
| Astellas Pharma US INC | $337.29 | 2019-2022 | |
| Pfizer INC. | $310.09 | 2019-2025 | |
| Allergan, INC. | $267.40 | 2019-2021 | |
| Amarin Pharma, INC. | $262.79 | 2020-2023 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.